SGW-Bio

SGW-Bio is a generative AI-driven biotechnology company focused on the advanced design of novel proteins and antibodies. Founded in 2023 by Guowei Song, the former lead of Baidu’s HelixFold team, the company utilizes cutting-edge deep learning models to predict and optimize biological molecules for therapeutic use. SGW-Bio's platform is designed to overcome traditional limitations in protein engineering by accelerating the discovery of candidates with superior binding affinity and stability. The company targets high-value applications in the biopharmaceutical sector, including the development of enzymes and therapeutic antibodies. By integrating computational excellence with biological validation, SGW-Bio aims to streamline the path from target identification to clinical candidate selection.